Phase 4 and Post-Marketing Commitments in the EU
Phase 4 and Post-Marketing Commitments in the EU Understanding Phase 4 and Post-Marketing Commitments in the EU Phase 4 clinical trials, also known as post-marketing studies, play a crucial role in ensuring that medicines remain safe and effective after regulatory approval. In the European Union (EU), these studies are governed by the EU Clinical Trial…
Read More “Phase 4 and Post-Marketing Commitments in the EU” »